Study Finds Gen Z Prioritized Wellness This Holiday Season: Lone Star Botanicals Is Helping Them Meet That Need

The Current Generation of Young Adults Balanced Frugality With Conviction to End 2025. Lone Star Botanicals' Robust Line of Clean Supplements Can Equip Them to Do Both in 2026. Lone Star Botanicals is a brand committed to robust quality standards and responsible sourcing. These corporate convictions align closely with new reports that find younger consumer […]

AI-Powered Humanoid Robots Billion Dollar Market Emerging as a High-Growth Automation Play for Global Investors

Market News Updates News Commentary Next-generation robotics platforms are expanding addressable markets and unlocking long-term recurring revenue potential The humanoid robot industry is influenced by evolving needs in personal assistance, healthcare, and industrial automation. Trends such as AI-driven human-robot interaction, advanced mobility and dexterity, and integration with IoT and cloud platforms directly enhance functionality and

Actuate Therapeutics Announces Plans to Expand Clinical Pipeline, Advancing Elraglusib Tablet into a Phase 1/2 Clinical Program in Refractory Cancers

(NasdaqGM:ACTU), -Initiation of phase 1 portion of the trial planned in 2H 2026 -Phase 2 portion of the trial will initiate development of the elraglusib tablet in specific indications, including refractory melanoma and additional target solid tumor and hematologic cancers -Program builds on early clinical evidence of monotherapy activity observed in immune checkpoint inhibitor (CPI)-refractory

Abundia Global Impact Group Publishes Updated Investor Presentation

(NYSE MKT:AGIG), Highlights vertically integrated waste-to-value platform and 2026 operational milestones HOUSTON, TX, Jan. 21, 2026 (GLOBE NEWSWIRE) — Abundia Global Impact Group, Inc. (NYSE American: AGIG) (“Abundia” or the “Company”), a low-carbon energy solutions company focused on converting biomass and plastics waste into high-value low-carbon fuels, announces it has published an updated investor presentation,

Actuate Therapeutics Announces Plans to Expand Clinical Pipeline, Advancing Elraglusib Tablet into a Phase 1/2 Clinical Program in Refractory Cancers

Actuate Therapeutics Announces Plans to Expand Clinical Pipeline, Advancing Elraglusib Tablet into a Phase 1/2 Clinical Program in Refractory Cancers GlobeNewswire January 21, 2026 -Initiation of phase 1 portion of the trial planned in 2H 2026 -Phase 2 portion of the trial will initiate development of the elraglusib tablet in specific indications, including refractory melanoma

Abundia Global Impact Group Publishes Updated Investor Presentation

Abundia Global Impact Group Publishes Updated Investor Presentation GlobeNewswire January 21, 2026 Highlights vertically integrated waste-to-value platform and 2026 operational milestones HOUSTON, TX, Jan. 21, 2026 (GLOBE NEWSWIRE) — Abundia Global Impact Group, Inc. (NYSE American: AGIG) (“Abundia” or the “Company”), a low-carbon energy solutions company focused on converting biomass and plastics waste into high-value

Better Blend Expands to Florida with Three Franchise-Owned Tampa Locations and Two Food Trucks

Better Blend, the fast-growing smoothie brand known for its low-sugar, high-protein smoothies, announced its expansion into Florida with three franchise-owned locations planned for the Tampa market, and two food trucks designed for community events, fitness activations, and local pop-ups. The Florida expansion marks Better Blend’s first entry into the state and reflects growing demand across

IMAGE Skincare Welcomes Back Co-Founder Dr. Marc Ronert as Chief Executive Officer

European Board-Certified Plastic Surgeon Returns to Lead Next Phase of Global Growth IMAGE Skincare, the globally recognized professional skincare brand, announced today the return of Dr. Marc Ronert, MD, PhD, as Chief Executive Officer. A European board-certified plastic surgeon and co-founder of IMAGE Skincare, Dr. Ronert steps into the CEO role to guide the brand

CRIO and Todata Partner to Bring Live Site Performance Intelligence to Users

For CRIO customers, the partnership means: — A fast, seamless integration path with SiteGrades. — Instant visibility into enrollment pace, capacity, and profitability, plus the ability to connect financial, HR, and other systems for a complete operational picture. — No per-user fees and no technical lift — entire organizations get access from day one. CRIO,

remedi Advances Sterilization-Based Medical Waste Processing to Enable Recycling and Landfill Diversion

Recycling-enabled approach supports hospital sustainability programs and unifies compliance, landfill diversion, and operational reliability remedi, a fully permitted and regulated medical waste processor, is advancing traditional sterilization-based medical waste management by enabling recycling and landfill diversion–helping hospital networks align compliance requirements with expanding sustainability goals. Across the U.S., hospital systems are increasingly establishing formal sustainability

Scroll to Top